Request Pricing

Global Infectious Disease Situation Update

Reporting Period: May 26- June 2, 2026

The AeroClenz Chief Medical Officer periodically reviews publicly available infectious disease surveillance reports from organizations such as the Centers for Disease Control and Prevention (CDC), World Health Organization (WHO), and European Centre for Disease Prevention and Control (ECDC).

These summaries are intended to provide general awareness of global infectious disease activity relevant to international travel, healthcare systems, and high-traffic indoor environments.

This information is provided for situational awareness only and does not constitute medical advice.

Key Takeaways

For the period of May 26- June 2, 2026, several notable global infectious disease trends were observed:

  • Ebola (Bundibugyo virus disease) remains the most significant emerging outbreak under international surveillance
    • Measles continues to present a substantial disruption risk due to ongoing outbreaks and travel-related transmission
    • Cholera remains active in multiple regions, particularly where water and sanitation infrastructure is limited
    • Hantavirus and Andes virus remain uncommon but important travel-health concerns in specific settings
    • Seasonal arboviral diseases, including West Nile virus, continue to gain relevance as Northern Hemisphere vector season advances

Top 5 Signals

1) Ebola (Bundibugyo Virus Disease) Remains the Primary Global Outbreak Signal 

International public-health agencies continue to monitor a significant Bundibugyo Ebola outbreak affecting the Democratic Republic of the Congo and Uganda.

Recent reporting indicates:

  • Approximately 321 confirmed cases and 48 confirmed deaths in the Democratic Republic of the Congo
    • 15 confirmed cases and one death reported in Uganda
    • Continued cross-border monitoring and surveillance efforts

The outbreak remains operationally significant because Bundibugyo virus currently has no approved vaccine or specific treatment, and response efforts are occurring in areas affected by displacement, insecurity, and population movement.

For the general traveling public, overall risk remains low.

2) Measles Remains the Highest Disruption Risk per Individual Case

CDC reported 1,983 confirmed measles cases in the United States as of May 28, 2026, with approximately 93% associated with outbreaks.

Ongoing global outbreaks and travel-associated importations continue to reinforce the importance of surveillance and rapid public-health response.

The combination of extreme transmissibility and resource-intensive contact investigations continues to make measles one of the most operationally significant infectious diseases worldwide.

3) Cholera Continues Across Multiple Regions

Cholera remains active globally, particularly in settings affected by:

  • Limited access to safe water
    • Inadequate sanitation infrastructure
    • Population displacement
    • Healthcare access challenges

Public-health agencies continue to monitor outbreaks in affected regions, with particular attention to humanitarian and fragile settings where disease burden can increase rapidly.

4) Hantavirus and Andes Virus Remain Important Travel-Health Considerations 

ECDC continues to monitor hantavirus activity, including Andes virus.

Although rare, Andes virus remains notable because limited person-to-person transmission has been documented under specific circumstances involving prolonged close contact.

These events remain uncommon but continue to be monitored due to their potential severity.

5) West Nile Virus and Seasonal Arboviruses Are Increasing in Relevance 

As vector season expands across the Northern Hemisphere, public-health agencies continue surveillance for mosquito-borne diseases, including West Nile virus.

Risk remains highly dependent on geographic location and environmental conditions.

Travel-health recommendations continue to emphasize mosquito bite prevention and awareness of symptoms following travel to affected areas.

Global Situation Overview

Ebola (Bundibugyo Virus Disease) 

The current Bundibugyo Ebola outbreak in Central Africa represents the most significant emerging infectious disease event during this reporting period.

While overall international spread risk remains low, public-health agencies continue to monitor:

  • Cross-border movement
    • Healthcare-associated transmission risks
    • Access to treatment and outbreak response resources

The absence of a licensed vaccine or specific therapy contributes to continued international attention.

Measles

Measles continues to circulate globally and remains a major public-health concern.

Recent CDC reporting highlights:

  • Continued outbreak activity in the United States
    • Ongoing international transmission
    • Travel-associated importation risks

Measles remains notable for its ability to generate large-scale contact investigations following a single exposure event.

Cholera 

Cholera remains one of the most significant waterborne diseases globally.

Current activity continues to be concentrated in regions where water, sanitation, and hygiene infrastructure face persistent challenges.

Outbreaks remain closely linked to environmental and humanitarian conditions rather than routine travel exposure.

Mpox

WHO’s most recent situation reporting indicates that mpox remains under active surveillance globally.

Although not a leading operational concern during this reporting period, mpox continues to be monitored because of:

  • International travel patterns
    • Ongoing transmission in affected regions
    • Evolving clade dynamics

Arboviruses and Vector-Borne Diseases

Mosquito-borne diseases remain important travel-health considerations.

Current areas of focus include:

  • West Nile virus surveillance in seasonal transmission zones
    • Destination-specific chikungunya risk
    • Ongoing dengue activity in multiple regions
    • Persistent low-level Zika virus circulation

Public-health agencies continue to emphasize prevention strategies and traveler awareness.

High-Consequence Pathogens 

In addition to Ebola, agencies continue monitoring other high-consequence infectious diseases.

Current assessments indicate:

  • No evidence of sustained international spread of recent Nipah virus events
    • Continued monitoring of emerging zoonotic disease threats
    • Low overall risk to the general public from currently reported events

Summary

The global infectious disease landscape for early June 2026 is characterized by continued monitoring of a significant Bundibugyo Ebola outbreak alongside persistent measles activity and ongoing travel-related infectious disease concerns.

Key themes include:

  • Ebola (Bundibugyo virus disease) as the leading emerging outbreak signal
    • Continued measles transmission and outbreak activity globally
    • Persistent cholera risk in infrastructure-limited settings
    • Ongoing monitoring of hantavirus and Andes virus activity
    • Increasing seasonal relevance of West Nile virus and other arboviruses

Public-health surveillance agencies continue to monitor these developments and publish updates as new information becomes available.

Sources referenced in this summary include the Centers for Disease Control and Prevention (CDC), the World Health Organization (WHO), the European Centre for Disease Prevention and Control (ECDC), and peer-reviewed literature.

To learn more about AeroClenz, visit www.aeroclenz.com. Follow AeroClenz on social media for updates on research and technology developments.

LinkedIn: https://www.linkedin.com/company/aeroclenz
Facebook: https://www.facebook.com/AeroClenz
Instagram: https://www.instagram.com/aeroclenz_

Get Updates Automatically
Translate »
Scroll to Top

Michael Stroup

Chief Operations Officer

Michael is a results-driven leader with 20 years of experience improving operations to achieve greater organizational effectiveness, productivity, and performance across multiple industries. Most recently Michael served as Integration Engineering Manager at CooperSurgical, a leading fertility medical device manufacturer. Prior to CSI, he has a proven track record of driving operational and engineering excellence within medical device, food, electronics and automotive industries by leading day to day operations and providing effective strategic leadership/execution.  His expertise includes, but is not limited to, global production set up, process improvements, machinery design and compliance. Michaels holds a Bachelor of Science in Mechanical Engineering Technology and Industrial Automotive Technology from Indiana State University and a Master of Science in Industrial Technology from Indiana State University.

Matt Saberton

CEO, Founder, Co-Inventor

Matt has been passionate about aviation from a young age, earning his private pilot’s license in high school. After obtaining a degree in Aviation and Aerospace Science, he began his career as a flight instructor and then became an air ambulance pilot, where he recognized the importance of cabin cleanliness.

Rising through the ranks at one of the largest worldwide charter airlines, Matt became Captain and later Chief Pilot, gaining deep insights into maintaining safe environments in aviation. This experience led him to found Aeroclenz, Inc., where he now serves as CEO.

Under his leadership, Aeroclenz has transitioned from an aerospace-focused company to a leader in UV disinfection solutions, offering custom products for both aerospace and terrestrial indoor applications. While the company’s roots are in aviation, its technologies now ensure high standards of cleanliness across various industries.

Jameson Trettenero

Director of Marketing

Jameson is a seasoned marketing expert with experience driving strategic marketing initiatives across a diverse array of industries. In his role, Jameson leads the marketing efforts with a focus on innovative growth strategies, brand elevation, and data-driven decision-making that align with the company’s overarching business goals.

Before joining Aeroclenz, Jameson held key leadership positions at top-tier digital agencies. In his agency experience, he spearheaded multi-divisional teams across disciplines including SEO, Paid Media, Analytics, and Creative. His strategic oversight and client-centric approach significantly enhanced client retention and business growth, particularly across enterprise-level accounts.

Jameson’s expertise extends to managing complex client relationships, advising C-level executives, and navigating the intricacies of the marketing landscape. His ability to harmonize creativity with analytics has consistently driven measurable success for clients, from Fortune 500 companies to emerging brands.